HAVCR2 and chronic myelomonocytic leukemia: TIM-3 expression has also been found to correlate to poor prognosis in other hematologic malignancies such as DLBCL, ALL, MDS, Chronic Myelogenous Leukemia (CML), and Chronic Myelomonocytic Leukemia (CMML) (112–115).